首页> 外文期刊>Clinical and applied thrombosis/hemostasis >Description and Evaluation of the Implementation of a Weight-Based, Nurse-Driven Heparin Nomogram in a Tertiary Academic Medical Center
【24h】

Description and Evaluation of the Implementation of a Weight-Based, Nurse-Driven Heparin Nomogram in a Tertiary Academic Medical Center

机译:在第三学术医疗中心实施权重的护士驱动的护士驱动的肝素NOM图的描述和评估

获取原文
获取原文并翻译 | 示例
           

摘要

Weight-based, nurse-driven heparin nomograms are reported in the medical literature to improve the time it takes to reach a minimum threshold for anticoagulation without compromising patient safety in specific indications or patient populations. This is the first report in the literature of an institution-wide protocol implementation and evaluation of effectiveness with simultaneous transition to an electronic health record. The purpose of implementing this practice change at our institution was to standardize practice, improve time to reach therapeutic anticoagulation, and improve patient safety. We conducted a retrospective analysis utilizing a pre/postimplementation design to compare outcomes. The primary end point evaluated was the time to reach minimum threshold value for therapeutic anticoagulation. Additionally, we assessed the percentage of patients who reached minimum threshold therapeutic anticoagulation within 24 hours, the percentage of patients with a critically supratherapeutic activated partial thromboplastin time (aPTT) value (= 120 seconds) during therapy, and a description of heparin titration for the first 4 aPTT results with nomogram use. Overall time to therapeutic anticoagulation decreased from a mean 18.7 to 11.7 hours (hazard ratio [HR] 1.59; 95% confidence interval 1.22-2.08; P .0005). Percentage of patients receiving therapeutic anticoagulation within 24 hours increased from 74.4 to 88.5 (odds ratio [OR 2.97, P = .002) and the percentage of patients with an aPTT = 120 seconds remained constant at 49.9 versus 46.8 (OR 0.92, P = .73). This practice change reduced time to therapeutic anticoagulation without an increase in the proportion of patients with a critically supratherapeutic aPTT at our institution.
机译:在医学文献中报告了基于重量的护士驱动的肝素载体载体,以改善达到最小阈值的时间,而不会影响特定适应症或患者群体的患者安全性。这是一个机构范围内协议的文献中的第一个报告,并评估了同时过渡到电子健康记录的有效性。在我们机构实施这种做法变革的目的是为了规范实践,提高达到治疗抗凝的时间,并改善患者安全。利用前/后期设计进行了比较结果,我们进行了回顾性分析。评估的主要终点是达到治疗抗凝凝血的最小阈值的时间。此外,我们还评估了在24小时内达到最低阈值治疗性抗凝凝血的患者的百分比,治疗期间批判性激活的部分血栓形成蛋白(APTT)值(& = 120秒)的百分比和肝素滴定的描述对于第一个4个APTT结果,NOM图使用。治疗抗凝的总时间从平均18.7至11.7小时(危险比[HR] 1.59; 95%置信区间1.22-2.08; p <.0005)减少(危险比[HR] 1.59; 05)。在24小时内接受治疗抗凝患者的百分比从74.4增加到88.5(opttt&gt的患者患者的百分比增加)增加到8.4.4℃。= 120秒保持恒定在49.9与46.8(或0.92,p = .73)。这种做法会减少到治疗抗凝的时间,而无需在我们所机构的患者患者的比例增加。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号